Financials
- Market Capitalization 586.53 M
- Employee 353
- Founded 2012
- CEO David Moatazedi
- Website www.evolus.com
- Headquarter Delaware, United States
- FIGI BBG005CX4HK8
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-13.61
売上高対価格比率
1.43
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2774 | AQST Aquestive Therapeutics, Inc. - Common Stock | 5.02 USD | -2.71% | +7.04% | +35.68% | +33.87% | 630.07 M USD | ||
| 2784 | TLRY Tilray Brands, Inc. - Common Stock | 4.59 USD | +0.44% | -3.97% | -1.29% | +258.59% | 625.17 M USD | ||
| 2945 | KMDA Kamada Ltd. - Ordinary Shares | 8.29 USD | +0.36% | -0.36% | +16.93% | +18.26% | 478.22 M USD | ||
| 3001 | BIOA BioAge Labs, Inc. - Common Stock | 9.65 USD | -4.27% | +0.84% | +1.58% | +26.97% | 442.91 M USD |